Journal of Generic Medicine – Editorial June 2021

Abstract

A USA watchdog agency recently warned that the backlog of FDA inspection could take years to complete. By comparison, some discovery pharmaceutical companies and some OTC companies along with one middle eastern generic pharmaceutical company have a debt ratio of around x1.5 gross debt/EBITDA. The largest generic pharmaceutical company Viatris (Pfizer-Upjohn-Mylan) expects 2021 sales to be dominated by Europe, with a 33% share of total sales (growing at +4% over the last year) compared to North America holding a smaller 27% share of total sales (which is declining at -1%). [Extracted from the article] Copyright of Journal of Generic Medicines is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)